AQIX LIMITED

SW7 2AZ (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£292,583

Jul 10 - Mar 11

AQIX RS-I - Basic development of a therapeutic formulation for the assessment and regeneration of donor organs otherwise regarded as marginal for transplantation

Innovate UK award to AQIX LIMITED

£59,632

Jan 12 - Oct 14

A pre-clinical feasibility study for the application of AQIX®RS-I as a prime and fluid management solution during cardiopulmonary bypass surgery

Innovate UK award to AQIX LIMITED and Martin Powell

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}